The First In Vitro Diagnostic Device for the Early Detection of Cardiac Ischemia

Project Information

AGLYC

Grant agreement ID: 849047

DOI 10.3030/849047

Project closed

EC signature date 12 April 2019

Start date 1 March 2019

End date 30 June 2022

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 2 727 139,00

EU contribution € 1 908 997,30

Coordinated by

GLYCARDIAL DIAGNOSTICS, SL
Spain

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Websites, patent fillings, videos etc. (1)

AGLYC public website

Website of the project.

Publications

Peer reviewed articles (1)

Glycosylated apolipoprotein J in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic events

Author(s): udit Cubedo , Teresa Padró, Gemma Vilahur, Filippo Crea, Robert F Storey, Jose Luis Lopez Sendon, Juan Carlos Kaski, Alessandro Sionis, Jordi Sans-Rosello, Estefanía Fernández-Peregrina, Alex Gallinat, Lina Badimon
Published in: European Heart Journal, Issue 2022 Jan 13;43(2), 2022, Page(s) 153-163, ISSN 0000-0000
Publisher: Oxford University Press
DOI: 10.1093/eurheartj/ehab691

Intellectual Property Rights

Patent (1)

ANTIBODIES SPECIFIC FOR GLYCOSYLATED APOJ AND USES THEREOF

Application/Publication number: 20 19078855
Date: 2019-10-23
Applicant(s): GLYCARDIAL DIAGNOSTICS, SL